查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1980183

眼科医疗设备市场规模、份额、成长率及全球产业分析：按类型、应用和地区划分，并预测至2026-2034年

Ophthalmic Devices Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 150 Pages | 商品交期: 请询问到货日

价格

眼科医疗设备市场成长要素

全球眼科医疗设备市场预计在2025年达到314.5亿美元，2026年成长至329亿美元，并在2034年达到484.4亿美元，预测期内复合年增长率（CAGR）为5%。 2025年，北美市场占据主导地位，市场份额达40.92%，这主要得益于先进人工水晶体（IOL）的普及、眼科手术量的激增以及主要市场参与者的强大影响力。

该市场涵盖眼科诊断和手术器械，以及隐形眼镜和眼部健康管理设备等视力保健产品。近视、高度近视、白内障、青光眼、糖尿病视网膜病变和老龄化黄斑部病变等视力障碍的日益普遍，正在推动全球需求成长。世界卫生组织 (WHO) 和布莱恩霍尔顿视觉研究所预测，到 2050 年，全球约 52% 的人口将患有近视，10% 的人口将患有高度近视，这凸显了眼科器械日益增长的需求。

市场驱动因素

视力障碍盛行率的不断上升和眼科手术数量的增加是市场成长的主要驱动因素。例如，2018年美国进行了约390万例白内障手术，反映出对手术器械的需求日益增长。此外，微创青光眼手术（MIG）植入物和三焦点人工水晶体植入等技术的进步也进一步推动了市场成长。

其他促成因素包括有利的报销政策、人均医疗保健支出不断增长以及患者眼部健康意识的提高。视力保健设备（尤其是隐形眼镜）的普及率正在不断提高，据估计，美国有4500万人使用隐形眼镜，为视力保健行业做出了重大贡献。

市场限制因素

眼科设备的高成本限制了新兴市场的成长。例如，飞秒雷射的价格在20万至40万美元之间，中小诊所难以负担。此外，新兴市场医疗基础设施不足、产品取得困难以及患者认知度低导致的治疗率低等问题，也持续阻碍市场扩张。

新冠疫情的影响

新冠疫情对市场造成了负面影响，尤其是在外科领域，眼科手术数量大幅下降。一项针对美国228家医院的分析显示，2020年3月至4月期间，眼科就诊量下降了81%，白内障手术量下降了97%。另一方面，由于封锁措施引发的恐慌性购买和囤积，眼药水等视力保健产品的需求却增加。

細項分析

副产品：

  • 受隐形眼镜和眼部保健产品使用量不断增加的推动，视力保健设备正引领市场。
  • 随着人工水晶体（IOL）技术的进步以及白内障和视网膜手术数量的增加，外科医疗设备也在不断发展。例如，2019年，爱尔康公司在美国推出了AcrySof IQ PanOptix三焦点人工水晶体，这是一项意义重大的创新。

按最终用户划分：

  • 由于等待时间短、引进先进设备等优势，眼科诊所占了最大的市场份额。
  • 在「其他」领域（包括门诊手术中心 (ASC) 和多专科诊所），我们看到美国和欧洲的需求不断增长。

区域趋势

  • 北美：预计到 2025 年市场规模将达到 128.7 亿美元，到 2026 年将达到 134.6 亿美元，其中美国在 2026 年将占 126.1 亿美元。这主要得益于先进人工水晶体的普及性和主要企业的强大影响力。
  • 欧洲：在政府投资和爱尔康公司推出的Vivity人工水晶体等创新产品的推动下，预计到2026年，英国市场将达到10.3亿美元，德国将达到23.1亿美元，这表明市场将显着增长。
  • 亚太地区：由于白内障、青光眼和干眼症的盛行率不断上升，预计该地区将快速成长。预计到2026年，日本市场规模将达到27.7亿美元，中国将达到37.1亿美元，印度将达到7.3亿美元。
  • 拉丁美洲、中东和非洲：市场份额的扩大和对隐形眼镜日益增长的认知正在推动市场成长。

主要企业及产业趋势

主要企业包括爱尔康、强生视力保健、博士伦、卡尔蔡司医疗、库博光学、依视路、豪雅和尼德克。这些公司正专注于研发、产品创新和拓展业务区域，以巩固其市场地位。

近期进展如下：

  • 2021 年 7 月：库博光学在美国推出了“Clarity 1-day”，这是第一款净塑胶中和的隐形眼镜。
  • 2020 年 11 月：爱尔康在 2020 年美国眼科学会虚拟会议上公布了 AcrySof IQ Vivity人工水晶体的关键数据。
  • 2020 年 9 月：蔡司国际推出了“蔡司 UVClean”，这是一款用于眼科诊所的消毒设备。
  • 2020 年 7 月：HOYA 推出了“Sensity Fast”，这是一款对光线有反应的光致变色镜片。

目录

第一章：引言

第二章执行摘要

第三章 市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机会

第四章：主要考虑因素

  • 2025年，产业主要发展趋势—併购和合作
  • 主要眼科疾病的流行病学－依主要国家划分
  • 新产品引进/核准（由主要企业审批）
  • 主要国家监理趋势概述
  • 眼科设备市场的技术进步

第五章：2021-2034年全球眼科医疗设备市场分析、洞察与预测

  • 主要发现与总结
  • 市场分析、洞察与预测：按产品类型划分
    • 外科
      • 植入
      • 消耗品
      • 装置
    • 视力保健
      • 隐形眼镜
      • 人工水晶体
  • 市场分析、洞察与预测：按最终用户划分
    • 医院
    • 眼科诊所
    • 其他的
  • 市场分析、洞察与预测：按地区划分
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

第六章：北美眼科医疗设备市场分析、洞察与预测（2021-2034年）

  • 国家
    • 我们
    • 加拿大

第七章：欧洲眼科医疗设备市场分析、洞察与预测（2021-2034年）

  • 国家
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 斯堪地那维亚
    • 其他欧洲国家

第八章：亚太地区眼科医疗设备市场分析、洞察与预测（2021-2034年）

  • 国家
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 东南亚
    • 其他亚太国家

第九章：拉丁美洲眼科医疗设备市场分析、洞察与预测（2021-2034年）

  • 国家
    • 巴西
    • 墨西哥
    • 其他拉丁美洲国家

第十章：中东和非洲眼科医疗设备市场分析、洞察与预测（2021-2034年）

  • 国家
    • 海湾合作委员会国家
    • 南非
    • 其他中东和非洲国家

第十一章 竞争分析

  • 主要行业趋势
  • 全球市占率分析（2021）
  • 公司简介
    • Alcon（Part of Novartis AG）
    • Johnson & Johnson Services, Inc.
    • Essilor
    • Bausch Health Companies
    • ZEISS International
    • HOYA
    • NIDEK CO., LTD
    • TOPCON
    • CooperVision
    • Other Prominent Players
Product Code: FBI102187

Growth Factors of ophthalmic devices Market

The global ophthalmic devices market was valued at USD 31.45 billion in 2025 and is projected to grow to USD 32.9 billion in 2026, reaching USD 48.44 billion by 2034, representing a CAGR of 5% during the forecast period. North America dominated the market in 2025 with a 40.92% share, driven by the widespread adoption of advanced intraocular lenses (IOLs), high volumes of ophthalmic surgeries, and a strong presence of major market players.

The market encompasses ophthalmic diagnostics and surgical devices, as well as vision care products such as contact lenses and ocular health devices. Increasing prevalence of vision disorders, including myopia, high myopia, cataracts, glaucoma, diabetic retinopathy, and age-related macular degeneration, is driving demand globally. According to the World Health Organization (WHO) and Brien Holden Vision Institute, by 2050, approximately 52% of the global population is expected to be affected by myopia and 10% by high myopia, highlighting the growing need for ophthalmic devices.

Market Drivers

The increasing prevalence of vision disorders, along with the rise in eye surgeries, is the primary driver for market growth. For instance, in the U.S., approximately 3.9 million cataract surgeries were performed in 2018, reflecting the growing demand for surgical devices. Additionally, technological advancements, such as the development of micro-invasive glaucoma (MIGs) surgical implants and trifocal intraocular lenses, have further propelled market growth.

Other drivers include favorable reimbursement policies, rising per capita healthcare expenditure, and increasing patient awareness of eye health. Vision care devices, particularly contact lenses, have seen higher adoption rates, with an estimated 45 million people in the U.S. using contact lenses, contributing significantly to the vision care segment.

Market Restraints

The high cost of ophthalmic devices limits growth in emerging countries. For example, femtosecond lasers cost between USD 200,000 and USD 400,000, making them less accessible to small and mid-sized clinics. Additionally, low treatment rates in emerging nations due to limited healthcare infrastructure, product accessibility, and patient awareness continue to restrain market expansion.

Impact of COVID-19

The COVID-19 pandemic negatively impacted the market, particularly the surgical segment, as ophthalmic procedures declined significantly. An analysis of 228 hospitals in the U.S. showed an 81% reduction in ophthalmology patient visits during March-April 2020, with cataract surgeries declining by 97%. Conversely, vision care devices such as eye-drops saw increased demand due to panic-buying and stockpiling amid lockdowns.

Segmentation Analysis

By Product:

  • Vision care devices dominate the market, driven by rising adoption of contact lenses and ocular health products.
  • Surgical devices are also growing due to innovations in intraocular lenses (IOLs) and the increasing number of cataract and retinal surgeries. For example, in 2019, Alcon launched the AcrySof IQ PanOptix Trifocal IOL, a key innovation in the U.S.

By End User:

  • Ophthalmic clinics hold the largest market share due to advantages such as shorter waiting times and adoption of advanced devices.
  • The others segment, including ambulatory surgical centers (ASCs) and multispecialty clinics, is witnessing growing demand in the U.S. and Europe.

Regional Insights

  • North America: Valued at USD 12.87 billion in 2025 and projected at USD 13.46 billion in 2026, with the U.S. accounting for USD 12.61 billion in 2026, fueled by advanced IOL adoption and a strong presence of key players.
  • Europe: Expected growth is significant, with the UK market projected at USD 1.03 billion and Germany at USD 2.31 billion in 2026, supported by government investments and innovative product launches like Alcon's Vivity IOL.
  • Asia Pacific: Rapid growth is projected due to rising incidence of cataract, glaucoma, and dry eye disease. The Japan market is projected at USD 2.77 billion, China at USD 3.71 billion, and India at USD 0.73 billion in 2026.
  • Latin America & Middle East/Africa: Market growth is driven by increasing manufacturer presence and rising awareness of contact lenses.

Key Players and Industry Developments

Leading companies include Alcon, Johnson & Johnson Vision Care, Inc., Bausch & Lomb Incorporated, Carl Zeiss Meditec, Cooper Companies, Inc., Essilor, Hoya Corporation, and NIDEK CO., LTD. These players are focused on R&D, product innovation, and geographical expansion to strengthen their market positions.

Recent developments include:

  • July 2021: CooperVision launched Clarity 1-day as the first net plastic-neutral contact lens in the U.S.
  • Nov 2020: Alcon presented pivotal data on AcrySof IQ Vivity IOL at the AAO 2020 virtual meeting.
  • Sept 2020: ZEISS International launched ZEISS UVClean disinfecting device for optometry clinics.
  • July 2020: Hoya launched Sensity Fast light-reactive lenses in the photochromic category.

Conclusion

The ophthalmic devices market is projected to grow from USD 31.45 billion in 2025 to USD 48.44 billion by 2034 at a CAGR of 5%, driven by rising prevalence of vision disorders, growing adoption of advanced devices, and increasing ophthalmic surgeries. While high device costs and low treatment rates in emerging nations remain challenges, technological advancements, innovative product launches, and expanding vision care awareness are expected to sustain market growth across all regions.

Segmentation By Product Type

  • Surgical
    • Implants
    • Consumables
    • Equipment
  • Vision Care
    • Contact Lens
    • Ocular Health

By End-user

  • Hospitals
  • Ophthalmic Clinics
  • Others

By Geography

  • North America
    • By Product
    • By End User
    • By Country
  • Europe
    • By Product
    • By End User
    • By Country/Sub-region
  • Asia Pacific
    • By Product
    • By End User
    • By Country/Sub-region
  • Latin America
    • By Product
    • By End User
    • By Country/Sub-region
  • The Middle East & Africa
    • By Product
    • By End User
    • By Country/Sub-region

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities

4. Key Insights

  • 4.1. Key Industry Developments - Mergers, Acquisitions, and Partnerships, 2025
  • 4.2. Epidemiology of Major Ocular Disease - For Key Countries
  • 4.3. Introduction of New Products / Approvals (by Major Players)
  • 4.4. Overview of Regulatory Scenario - Key Countries
  • 4.5. Technological Advancements in Ophthalmic Devices Market

5. Global Ophthalmic Devices Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Key Findings / Summary
  • 5.2. Market Analysis, Insights and Forecast - By Product Type
    • 5.2.1. Surgical
      • 5.2.1.1. Implants
      • 5.2.1.2. Consumables
      • 5.2.1.3. Equipment
    • 5.2.2. Vision Care
      • 5.2.2.1. Contact Lenses
      • 5.2.2.2. Intraocular Lenses
  • 5.3. Market Analysis, Insights and Forecast - By End-user
    • 5.3.1. Hospitals
    • 5.3.2. Ophthalmic Clinics
    • 5.3.3. Others
  • 5.4. Market Analysis, Insights and Forecast - By Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East & Africa

6. North America Ophthalmic Devices Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Key Findings / Summary
  • 6.2. Market Analysis - By Product Type
    • 6.2.1. Surgical
      • 6.2.1.1. Implants
      • 6.2.1.2. Consumables
      • 6.2.1.3. Equipment
    • 6.2.2. Vision Care
      • 6.2.2.1. Contact Lenses
      • 6.2.2.2. Intraocular Lenses
  • 6.3. Market Analysis - By End-user
    • 6.3.1. Hospitals
    • 6.3.2. Ophthalmic Clinics
    • 6.3.3. Others
  • 6.4. Market Analysis - By Country
    • 6.4.1. U.S.
    • 6.4.2. Canada

7. Europe Ophthalmic Devices Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Key Findings / Summary
  • 7.2. Market Analysis - By Product Type
    • 7.2.1. Surgical
      • 7.2.1.1. Implants
      • 7.2.1.2. Consumables
      • 7.2.1.3. Equipment
    • 7.2.2. Vision Care
      • 7.2.2.1. Contact Lenses
      • 7.2.2.2. Intraocular Lenses
  • 7.3. Market Analysis - By End-user
    • 7.3.1. Hospitals
    • 7.3.2. Ophthalmic Clinics
    • 7.3.3. Others
  • 7.4. Market Analysis - By Country/ Sub-region
    • 7.4.1. U.K.
    • 7.4.2. Germany
    • 7.4.3. France
    • 7.4.4. Spain
    • 7.4.5. Italy
    • 7.4.6. Scandinavia
    • 7.4.7. Rest of Europe

8. Asia Pacific Ophthalmic Devices Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Key Findings / Summary
  • 8.2. Market Analysis - By Product Type
    • 8.2.1. Surgical
      • 8.2.1.1. Implants
      • 8.2.1.2. Consumables
      • 8.2.1.3. Equipment
    • 8.2.2. Vision Care
      • 8.2.2.1. Contact Lenses
      • 8.2.2.2. Intraocular Lenses
  • 8.3. Market Analysis - By End-user
    • 8.3.1. Hospitals
    • 8.3.2. Ophthalmic Clinics
    • 8.3.3. Others
  • 8.4. Market Analysis - By Country/ Sub-region
    • 8.4.1. Japan
    • 8.4.2. China
    • 8.4.3. India
    • 8.4.4. Australia
    • 8.4.5. Southeast Asia
    • 8.4.6. Rest of Asia Pacific

9. Latin America Ophthalmic Devices Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Key Findings / Summary
  • 9.2. Market Analysis - By Product Type
    • 9.2.1. Surgical
      • 9.2.1.1. Implants
      • 9.2.1.2. Consumables
      • 9.2.1.3. Equipment
    • 9.2.2. Vision Care
      • 9.2.2.1. Contact Lenses
      • 9.2.2.2. Intraocular Lenses
  • 9.3. Market Analysis - By End-user
    • 9.3.1. Hospitals
    • 9.3.2. Ophthalmic Clinics
    • 9.3.3. Others
  • 9.4. Market Analysis - By Country/ Sub-region
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America

10. Middle East & Africa Ophthalmic Devices Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Key Findings / Summary
  • 10.2. Market Analysis - By Product Type
    • 10.2.1. Surgical
      • 10.2.1.1. Implants
      • 10.2.1.2. Consumables
      • 10.2.1.3. Equipment
    • 10.2.2. Vision Care
      • 10.2.2.1. Contact Lenses
      • 10.2.2.2. Intraocular Lenses
  • 10.3. Market Analysis - By End-user
    • 10.3.1. Hospitals
    • 10.3.2. Ophthalmic Clinics
    • 10.3.3. Others
  • 10.4. Market Analysis - By Country/ Sub-region
    • 10.4.1. GCC Countries
    • 10.4.2. South Africa
    • 10.4.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Key Industry Developments
  • 11.2. Global Market Share Analysis (2021)
  • 11.3. Company Profiles (Overview, Products, SWOT analysis, Recent developments, strategies, financials (based on availability))
    • 11.3.1. Alcon (Part of Novartis AG)
      • 11.3.1.1. Overview,
      • 11.3.1.2. Products,
      • 11.3.1.3. SWOT analysis,
      • 11.3.1.4. Recent developments,
      • 11.3.1.5. strategies,
      • 11.3.1.6. financials (based on availability)
    • 11.3.2. Johnson & Johnson Services, Inc.
      • 11.3.2.1. Overview,
      • 11.3.2.2. Products,
      • 11.3.2.3. SWOT analysis,
      • 11.3.2.4. Recent developments,
      • 11.3.2.5. strategies,
      • 11.3.2.6. financials (based on availability)
    • 11.3.3. Essilor
      • 11.3.3.1. Overview,
      • 11.3.3.2. Products,
      • 11.3.3.3. SWOT analysis,
      • 11.3.3.4. Recent developments,
      • 11.3.3.5. strategies,
      • 11.3.3.6. financials (based on availability)
    • 11.3.4. Bausch Health Companies
      • 11.3.4.1. Overview,
      • 11.3.4.2. Products,
      • 11.3.4.3. SWOT analysis,
      • 11.3.4.4. Recent developments,
      • 11.3.4.5. strategies,
      • 11.3.4.6. financials (based on availability)
    • 11.3.5. ZEISS International
      • 11.3.5.1. Overview,
      • 11.3.5.2. Products,
      • 11.3.5.3. SWOT analysis,
      • 11.3.5.4. Recent developments,
      • 11.3.5.5. strategies,
      • 11.3.5.6. financials (based on availability)
    • 11.3.6. HOYA
      • 11.3.6.1. Overview,
      • 11.3.6.2. Products,
      • 11.3.6.3. SWOT analysis,
      • 11.3.6.4. Recent developments,
      • 11.3.6.5. strategies,
      • 11.3.6.6. financials (based on availability)
    • 11.3.7. NIDEK CO., LTD
      • 11.3.7.1. Overview,
      • 11.3.7.2. Products,
      • 11.3.7.3. SWOT analysis,
      • 11.3.7.4. Recent developments,
      • 11.3.7.5. strategies,
      • 11.3.7.6. financials (based on availability)
    • 11.3.8. TOPCON
      • 11.3.8.1. Overview,
      • 11.3.8.2. Products,
      • 11.3.8.3. SWOT analysis,
      • 11.3.8.4. Recent developments,
      • 11.3.8.5. strategies,
      • 11.3.8.6. financials (based on availability)
    • 11.3.9. CooperVision
      • 11.3.9.1. Overview,
      • 11.3.9.2. Products,
      • 11.3.9.3. SWOT analysis,
      • 11.3.9.4. Recent developments,
      • 11.3.9.5. strategies,
      • 11.3.9.6. financials (based on availability)
    • 11.3.10. Other Prominent Players
      • 11.3.10.1. Overview,
      • 11.3.10.2. Products,
      • 11.3.10.3. SWOT analysis,
      • 11.3.10.4. Recent developments,
      • 11.3.10.5. strategies,
      • 11.3.10.6. financials (based on availability)

List of Tables

  • Table 1: Global Ophthalmic Devices Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 2: Global Ophthalmic Devices Market Revenue (USD billion) Forecast, by Surgical, 2021-2034
  • Table 3: Global Ophthalmic Devices Market Revenue (USD billion) Forecast, by Vision Care, 2021-2034
  • Table 4: Global Ophthalmic Devices Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 5: Global Ophthalmic Devices Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 6: North America Ophthalmic Devices Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 7: North America Ophthalmic Devices Market Revenue (USD billion) Forecast, by Surgical, 2021-2034
  • Table 8: North America Ophthalmic Devices Market Revenue (USD billion) Forecast, by Vision Care, 2021-2034
  • Table 9: North America Ophthalmic Devices Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 10: North America Ophthalmic Devices Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 11: Europe Ophthalmic Devices Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 12: Europe Ophthalmic Devices Market Revenue (USD billion) Forecast, by Surgical, 2021-2034
  • Table 13: Europe Ophthalmic Devices Market Revenue (USD billion) Forecast, by Vision Care, 2021-2034
  • Table 14: Europe Ophthalmic Devices Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 15: Europe Ophthalmic Devices Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 16: Asia Pacific Ophthalmic Devices Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 17: Asia Pacific Ophthalmic Devices Market Revenue (USD billion) Forecast, by Surgical, 2021-2034
  • Table 18: Asia Pacific Ophthalmic Devices Market Revenue (USD billion) Forecast, by Vision Care, 2021-2034
  • Table 19: Asia Pacific Ophthalmic Devices Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 20: Asia Pacific Ophthalmic Devices Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 21: Latin America Ophthalmic Devices Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 22: Latin America Ophthalmic Devices Market Revenue (USD billion) Forecast, by Surgical, 2021-2034
  • Table 23: Latin America Ophthalmic Devices Market Revenue (USD billion) Forecast, by Vision Care, 2021-2034
  • Table 24: Latin America Ophthalmic Devices Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 25: Latin America Ophthalmic Devices Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 26: Middle East & Africa Ophthalmic Devices Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 27: Middle East & Africa Ophthalmic Devices Market Revenue (USD billion) Forecast, by Surgical, 2021-2034
  • Table 28: Middle East & Africa Ophthalmic Devices Market Revenue (USD billion) Forecast, by Vision Care, 2021-2034
  • Table 29: Middle East & Africa Ophthalmic Devices Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 30: Middle East & Africa Ophthalmic Devices Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Ophthalmic Devices Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Ophthalmic Devices Market Value Share (%), by Product Type, 2025 & 2034
  • Figure 3: Global Ophthalmic Devices Market Forecast (USD billion), by Surgical, 2021-2034
  • Figure 4: Global Ophthalmic Devices Market Forecast (USD billion), by Vision Care, 2021-2034
  • Figure 5: Global Ophthalmic Devices Market Value Share (%), by End-user, 2025 & 2034
  • Figure 6: Global Ophthalmic Devices Market Forecast (USD billion), by Hospitals, 2021-2034
  • Figure 7: Global Ophthalmic Devices Market Forecast (USD billion), by Ophthalmic Clinics, 2021-2034
  • Figure 8: Global Ophthalmic Devices Market Forecast (USD billion), by Others, 2021-2034
  • Figure 9: Global Ophthalmic Devices Market Value (USD billion), by Region, 2025 & 2034
  • Figure 10: North America Ophthalmic Devices Market Value (USD billion), by Product Type, 2025 & 2034
  • Figure 11: North America Ophthalmic Devices Market Value Share (%), by Product Type, 2025
  • Figure 12: North America Ophthalmic Devices Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 13: North America Ophthalmic Devices Market Value Share (%), by End-user, 2025
  • Figure 14: North America Ophthalmic Devices Market Value (USD billion), By Country, 2025 & 2034
  • Figure 15: North America Ophthalmic Devices Market Value Share (%), By Country, 2025
  • Figure 16: Europe Ophthalmic Devices Market Value (USD billion), by Product Type, 2025 & 2034
  • Figure 17: Europe Ophthalmic Devices Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 18: Europe Ophthalmic Devices Market Value Share (%), by End-user, 2025
  • Figure 19: Europe Ophthalmic Devices Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 20: Europe Ophthalmic Devices Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 21: Asia Pacific Ophthalmic Devices Market Value (USD billion), by Product Type, 2025 & 2034
  • Figure 22: Asia Pacific Ophthalmic Devices Market Value Share (%), by Product Type, 2025
  • Figure 23: Asia Pacific Ophthalmic Devices Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 24: Asia Pacific Ophthalmic Devices Market Value Share (%), by End-user, 2025
  • Figure 25: Asia Pacific Ophthalmic Devices Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 26: Asia Pacific Ophthalmic Devices Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 27: Latin America Ophthalmic Devices Market Value (USD billion), by Product Type, 2025 & 2034
  • Figure 28: Latin America Ophthalmic Devices Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 29: Latin America Ophthalmic Devices Market Value Share (%), by End-user, 2025
  • Figure 30: Latin America Ophthalmic Devices Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 31: Latin America Ophthalmic Devices Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 32: Middle East & Africa Ophthalmic Devices Market Value (USD billion), by Product Type, 2025 & 2034
  • Figure 33: Middle East & Africa Ophthalmic Devices Market Value Share (%), by Product Type, 2025
  • Figure 34: Middle East & Africa Ophthalmic Devices Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 35: Middle East & Africa Ophthalmic Devices Market Value Share (%), by End-user, 2025
  • Figure 36: Middle East & Africa Ophthalmic Devices Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 37: Middle East & Africa Ophthalmic Devices Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 38: Global Ophthalmic Devices Market Share (%), By Company, 2025